Literature DB >> 25108813

Radical nephroureterectomy versus endoscopic procedures for the treatment of localised upper tract urothelial carcinoma: a meta-analysis and a systematic review of current evidence from comparative studies.

R Yakoubi1, P Colin2, T Seisen3, P Léon3, L Nison4, G Bozzini4, S F Shariat5, M Rouprêt6.   

Abstract

The conservative management of upper tract urothelial carcinoma (UTUC) has seen important developments over the last 10 years with advances in endoscopy. Our aim was to compare the available evidence regarding the impact of endoscopic nephron sparing procedures (NSP) and radical nephroureterectomy (RNU) on survival of upper tract urothelial carcinoma (UTUC). A critical review of Pubmed/Medline, Embase and the Cochrane Central Register of Controlled Trials was performed in July 2013 according to the preferred reporting items for systematic reviews and meta-analysis (PRISMA) statement. Overall, eight publications were selected for inclusion in this meta-analysis but all of them were retrospective or non-randomised comparative studies. The primary end points were the overall and cancer-specific survivals (OS and CSS) in the two treatment groups. We achieved to pool data on 1002 patients diagnosed with localised UTUC and treated either by endoscopic NSP (n = 322) or by RNU (n = 680). No significant difference was found in terms of OS and CSS between RNU and endoscopic NSP (HR = 1.47 and p = 0.31; HR = 0.96 and p = 0.91, respectively). However, the low level of evidence (3b) and the heterogeneity of the studies limited the quality of the results. In the absence of prospective and randomised studies, the equivalent oncologic control for endoscopic NSP and RNU is not provided by this meta-analysis. Multicentre prospective studies are urgently needed to assess the oncologic outcomes of UTUC with endoscopic management. In the next multicentre studies, the patients should be matched on the basis of the tumour stage (imaging) and grade (biopsy) at diagnosis.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Renal pelvis; Survival; Ureter; Urothelial carcinomas

Mesh:

Year:  2014        PMID: 25108813     DOI: 10.1016/j.ejso.2014.06.007

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  32 in total

1.  [Surgical management for upper urinary tract transitional cell carcinoma].

Authors:  S Schmidt; A Spek
Journal:  Urologe A       Date:  2015-08       Impact factor: 0.639

Review 2.  [Instillation therapies for urothelial carcinoma of the upper urinary tract].

Authors:  P Bosshard; G N Thalmann; B Roth
Journal:  Urologe A       Date:  2019-01       Impact factor: 0.639

3.  Treatment utilization and overall survival in patients receiving radical nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma: evaluation of updated treatment guidelines.

Authors:  Alexander Upfill-Brown; Andrew T Lenis; Izak Faiena; Amirali H Salmasi; David C Johnson; Aydin Pooli; Alexandra Drakaki; Kiran Gollapudi; Jeremy Blumberg; Allan J Pantuck; Karim Chamie
Journal:  World J Urol       Date:  2018-09-28       Impact factor: 4.226

4.  A patient with synchronous bilateral low-grade upper tract urothelial carcinoma who underwent nephroureterectomy and total ureterectomy with ileal ureteric replacement.

Authors:  Yoshinori Matsuda; Takamitsu Inoue; Atsushi Maeno; Atsushi Koizumi; Ryohei Yamamoto; Taketoshi Nara; Sohei Kanda; Kazuyuki Numakura; Mitsuru Saito; Shintaro Narita; Shigeru Satoh; Tomonori Habuchi
Journal:  Int Cancer Conf J       Date:  2020-03-03

5.  Normal Porcine Ureter Retains Lumen Wall Integrity but Not Patency Following Catheter-Directed Irreversible Electroporation: Imaging and Histologic Assessment over 28 Days.

Authors:  Govindarajan Srimathveeravalli; Francois Cornelis; Thomas Wimmer; Sebastien Monette; Simon Y Kimm; Majid Maybody; Stephen B Solomon; Jonathan A Coleman; Jeremy C Durack
Journal:  J Vasc Interv Radiol       Date:  2017-03-30       Impact factor: 3.464

Review 6.  Upper tract urothelial carcinoma: Paradigm shift towards nephron sparing management.

Authors:  Julia V Fiuk; Brad F Schwartz
Journal:  World J Nephrol       Date:  2016-03-06

Review 7.  Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma.

Authors:  Rao S Mandalapu; Mesut Remzi; Theo M de Reijke; Vitaly Margulis; J Palou; A Kapoor; Ofer Yossepowitch; Jonathan Coleman; Olivier Traxer; J Kyle Anderson; James Catto; Jean de la Rosette; Timothy O'Brien; Anthony Zlotta; Surena F Matin
Journal:  World J Urol       Date:  2016-05-27       Impact factor: 4.226

8.  Importance of long-term follow-up after endoscopic management for upper tract urothelial carcinoma and factors leading to surgical management.

Authors:  Anand Mohapatra; Seth A Strope; Nick Liu; Andrew Winer; Nicole E Benfante; Jonathan A Coleman; Joel Vetter; Katie S Murray
Journal:  Int Urol Nephrol       Date:  2020-03-11       Impact factor: 2.370

Review 9.  A systematic review and meta-analysis of oncological and renal function outcomes obtained after segmental ureterectomy versus radical nephroureterectomy for upper tract urothelial carcinoma.

Authors:  D Fang; T Seisen; K Yang; P Liu; X Fan; N Singla; G Xiong; L Zhang; X Li; L Zhou
Journal:  Eur J Surg Oncol       Date:  2016-08-25       Impact factor: 4.424

10.  Nephron sparing endoscopic treatment for primary carcinoma of the renal calyx: A case report and literature review.

Authors:  Q I Wang; Tong-Wen Ou; Jia-Wei Xu; Jin Li; Ali Borazjani; Chun-Song Jia; X U Wang; Hao Yan
Journal:  Mol Clin Oncol       Date:  2016-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.